Bhalla Narinder Pal's Form 4 filing
Lexeo Therapeutics, Inc. (LXEO) · filed Jul 1, 2026
- Accession no.
- 0002109299-26-000007
- Filed
- Jul 1, 2026, 6:48 PM ET
- Trade date
- Jun 29-Jul 1, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $98.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bhalla Narinder PalCIK 0002109299 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 29, 2026 | Common Stock | AGrant or awardAcquired | +55,000 | $0.00 | $0 | 104,500 | Direct | |
| Jul 1, 2026 | Common Stock | SSaleDisposed | −22,306 | $4.42 | −$98,592.52 | 82,194 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.